Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates

Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates

Background: Increasing numbers of immunocompromised patients have resulted in greater incidence of invasive fungal infections with high mortality. Candida albicans infections dominate, but during the last decade, Candida glabrata has become the second highest cause of candidemia in the United States...

Full description

Bibliographic Details
Main Authors: Kari-Mette Andersen, Anne Karin Kristoffersen, André Ingebretsen, Katharina Johnsen Vikholt, Ulf Thore Örtengren, Ingar Olsen, Morten Enersen, Peter Gaustad
Format: Article
Language:English
Published: Taylor & Francis Group 2016-02-01
Series:Journal of Oral Microbiology
Subjects:
C. glabrata
identification
biochemical
MALDI-TOF
MICs
Online Access:http://www.journaloforalmicrobiology.net/index.php/jom/article/view/29849/44789

Similar Items

Similar Items